The presence of BRCA1 germline alteration is more closely involved in HRD than that of BRCA2, and it is anticipated that BRCA-associated cancer may be differentiated even in the absence of BRCA1 germline mutation if a similar expression profile is exhibited. This evidence concerns the gene BRCA1 and cancer.